{
  "docId": "019de072-50fd-76be-bc50-13d10a429187",
  "docSlug": "745181b5445c8f31a0d7e29e54da559e",
  "documentTitle": "Chimerix | Results Presentation Deck | 12 slides",
  "authorId": "chimerix",
  "authorName": "Chimerix",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 2,
  "pageCount": 12,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "disclaimer",
  "function": "other",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-50fd-76be-bc50-13d10a429187/2",
  "deckHref": "/decks/019de072-50fd-76be-bc50-13d10a429187",
  "deckJsonHref": "/decks/019de072-50fd-76be-bc50-13d10a429187.json",
  "deckAnchorHref": "/decks/019de072-50fd-76be-bc50-13d10a429187#slide-2",
  "components": [
    {
      "bbox": {
        "h": 0.556,
        "w": 0.924,
        "x": 0.038,
        "y": 0.281
      },
      "kind": "disclaimer",
      "text": "These slides contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Among the factors and risks that could cause actual results to differ materially from those indicated in the forward-looking statements are risks that the current pre-clinical or clinical study data for CMX521 will not support accelerated, or any, regulatory approval; risks that ongoing or future studies/trials may not be successful or replicate previous trial results, or may not be predictive of real-world results or of results in subsequent trials; risks and uncertainties relating to competitive products and technological changes that may limit demand for our drugs; risks that our drugs may be precluded from commercialization by the proprietary rights of third parties; and additional risks set forth in the Company's filings with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this release. The Company disclaims, however, any intent or obligation to update these forward-looking statements.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4812bf13-dcbc-42e5-95cd-6d8dc2a586c9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.422,
        "x": 0.289,
        "y": 0.074
      },
      "kind": "title",
      "text": "Forward-Looking Statements",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1575ebbe-bbd2-4eea-990b-e3ba961c4b45",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}